# Richard J. Barohn

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-j-barohn/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,439 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 79 |
| i10-index | 188 |
| OpenAlex ID | https://openalex.org/A5111656786 |
| Works | 346 |

## Researcher papers

- [2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology/)
- [2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups](https://scholariq.org/papers/2017-european-league-against-rheumatism-american-college-of-rheumatology-2/)
- [Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial](https://scholariq.org/papers/efficacy-of-minocycline-in-patients-with-amyotrophic-lateral-sclerosis-a-phase/)
- [Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ataluren-in-patients-with-nonsense-mutation-duchenne-muscular-dystrophy-act-dmd/)
- [Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C‐HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF‐36), Child Health Questionnaire (CHQ), Physician Global Damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index‐2 (FI‐2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI)](https://scholariq.org/papers/measures-of-adult-and-juvenile-dermatomyositis-polymyositis-and-inclusion-body/)
- [Primary lateral sclerosis: consensus diagnostic criteria](https://scholariq.org/papers/primary-lateral-sclerosis-consensus-diagnostic-criteria/)
- [Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III](https://scholariq.org/papers/phase-ii-trial-of-coq10-for-als-finds-insufficient-evidence-to-justify-phase-iii/)
- [Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS](https://scholariq.org/papers/validation-of-serum-neurofilaments-as-prognostic-and-potential-pharmacodynamic/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Genetic Neurodegenerative Diseases](https://scholariq.org/topics/genetic-neurodegenerative-diseases/)
- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Inflammatory Myopathies and Dermatomyositis](https://scholariq.org/topics/inflammatory-myopathies-and-dermatomyositis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.